Novavax Beats Expectations Despite Q3 Loss
Update: 2025-11-06
Description
Novavaxs Q3 financial results reveal a mixed financial picture: a net loss of $202.4 million, or $1.25 per share, but adjusted for certain costs, the loss was $0.62 per share, surpassing analysts expectations. Revenue of $70.4 million also exceeded forecasts, indicating positive movement in their financial performance.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
